
Vripio 15 Tablet
Marketer
Vridam Healthcare Pvt Ltd
Salt Composition
Pioglitazone (15mg)
Overview Vripio 15 Tablet
Diabex 15mg tablets are indicated for managing type 2 diabetes in adult patients. This medication assists in regulating blood glucose, thus mitigating the risk of severe diabetic complications such as renal impairment and vision loss. Diabex 15mg may be administered alone or in conjunction with other therapies. It can be taken with or without food, but consistent daily dosing at the same time is crucial for optimal efficacy. Dosage will be determined by your physician and may be adjusted based on treatment response. Continuous use is recommended, even with well-controlled blood sugar, as abrupt cessation can lead to hyperglycemia and increased risk of nephropathy, blindness, neuropathy, and limb amputation. Remember, Diabex 15mg is one component of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are critical for effective diabetes control. Common adverse effects include cephalalgia, sinusitis, myalgia, and pharyngitis. Report any persistent or bothersome side effects to your physician. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior to commencing treatment, inform your physician of any history of cardiovascular disease, thyroid disorders, or endocrine imbalances. Pregnancy or breastfeeding necessitates consultation with your doctor before initiating therapy. Regular blood glucose monitoring is essential, and your physician may recommend blood tests to monitor hematological parameters and liver function.
Uses of Vripio 15 Tablet
Managing Type 2 Diabetes
Major Benefits of Vripio 15 Tablet:
Administer this medication precisely as prescribed by your physician, both in terms of dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vripio 15 Tablet can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Vripio 15 Tablet:
- Headache
- Sore throat
- Sinus inflammation
- Muscle pain
How to use Vripio 15 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Vripio 15 Tablet. Ingest the tablet whole; do not crush, chew, or break it. While Vripio 15 Tablet can be taken with or without food, consistent timing is recommended.
How Vripio 15 Tablet works:
Invokana 15mg tablets manage type 2 diabetes. Their mechanism involves enhancing the body's responsiveness to insulin, thereby regulating blood glucose.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol consumption while taking Vripio 15 Tablet.
PregnancyCONSULT YOUR DOCTOR
Using Vripio 15 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before use.
Breast feedingCAUTION
Use Vripio 15 Tablet cautiously while breastfeeding. Discontinue breastfeeding until maternal treatment concludes and the medication is fully cleared from the mother's system. Closely observe the infant's blood glucose levels throughout the treatment period.
DrivingSAFE
Driving ability is typically unaffected by Vripio 15 Tablet.
KidneySAFE IF PRESCRIBED
Vripio 15 Tablet poses no safety concerns for patients with kidney impairment; no dosage modification is necessary.
LiverCAUTION
Patients with liver impairment should use Vripio 15 Tablet cautiously, potentially requiring dosage modification. Physician consultation is advised. Vripio 15 Tablet is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Vripio 15 Tablet :
Omit any missed Vripio 15 Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Vripio 15 Tablet
| Label | Value |
|---|---|
| Chemical Type | TZD derivative |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
| Behavior Class | PPAR-gamma agonist (thiazolidinedione) |
